Earnings call transcript: Kyndryl Holdings misses Q4 2026 earnings expectations

Kyndryl missed Q4 FY2026 expectations with EPS of $0.18 versus $0.49 consensus and revenue of $3.77B versus $3.98B, while pre-market shares fell 13.64% to $13.39. Full-year revenue was flat at $15.1B, but adjusted EBITDA rose to $2.7B and margin expanded 100bps; hyperscaler-related revenue increased 59% to $1.9B. Management guided FY2027 revenue to flat to down 2% in constant currency and cited continued sales-cycle elongation and IBM-related headwinds, partly offset by stronger consult and AI-led modernization demand.

Analysis

KD is becoming a cleaner “quality-at-a-reasonable-price” story, but the market is likely over-discounting the revenue miss because the negative driver is mix, not margin erosion. The second-order implication is that IBM-related content displacement lowers top-line but also mechanically improves headline software dependency and makes the remaining book more consult-heavy and higher ROIC; that’s why the earnings bridge can still support the balance sheet and buybacks even if reported growth stays soft. The near-term problem is that investors will keep anchoring on revenue deceleration until they see a sustained inflection in book-to-bill conversion, not just backlog commentary.

The real competitive winner is anyone with adjacent modernization exposure and stronger balance-sheet optionality: IBM loses content capture inside customer stacks, while hyperscaler partners and infrastructure vendors can win share as clients split workloads across private cloud, public cloud, and sovereignty-constrained environments. That means the revenue leakage at KD is not necessarily lost IT spend; it is often re-routed spend, which creates a longer-duration replatforming cycle and supports consult demand, but also delays recognition. The key catalyst is not macro stabilization—it is deal conversion in Europe and regulated industries, where one or two large scope expansions can change sentiment quickly because the pipeline is already large and management is signaling that new-scope mix is improving.

Consensus is treating this as a standard earnings miss, but the bigger issue is guidance credibility around the path to 2028 growth. If IBM headwinds remain structurally non-neutral, the market will haircut the revenue target even if pre-tax and FCF targets hold, and that creates a valuation asymmetry: upside is capped until revenue inflects, while downside is protected by cash generation and buybacks. The trade here is to lean into that asymmetry via options or a pair rather than outright exposure, because the next leg will be driven by booking conversion cadence over the next 1-2 quarters rather than by current quarter fundamentals.

Key Decisions for Investors

• Short KD on the open only if the selloff extends into -12% to -15% and stabilizes; target a 4-6 week mean reversion trade back toward pre-earnings levels if management commentary on new-scope conversion holds.
• Prefer a KD call-spread funded by stock sale after post-earnings weakness: buy 3-6 month upside optionality on a 2027/2028 backlog conversion re-rate while capping theta if revenue remains noisy.
• Pair trade: long IBM / short KD for 1-2 quarters if you want to isolate the content-capture dynamic; KD bears the revenue leakage, while IBM retains the direct relationship premium. Use a tight stop if KD signs a large direct-to-consult conversion deal in Europe.
• For a more risk-controlled expression, buy KD December downside puts only on any bounce above the post-earnings trough; the setup works if the market realizes 2027 guidance can stay flat/down while 2028 revenue optimism gets pushed out.
• Avoid chasing AVGO/DELL off this print; there is no direct beneficiary unless broader client modernization budgets re-accelerate, which is a slower 6-12 month thesis rather than an immediate catalyst.